EPINEPHRINE (AUTOINJECTOR) Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Epinephrine (autoinjector), and what generic alternatives are available?
Epinephrine (autoinjector) is a drug marketed by Teva Pharms Usa and is included in one NDA.
The generic ingredient in EPINEPHRINE (AUTOINJECTOR) is epinephrine. There is one drug master file entry for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the epinephrine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Epinephrine (autoinjector)
A generic version of EPINEPHRINE (AUTOINJECTOR) was approved as epinephrine by BPI LABS on July 29th, 2014.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for EPINEPHRINE (AUTOINJECTOR)?
- What are the global sales for EPINEPHRINE (AUTOINJECTOR)?
- What is Average Wholesale Price for EPINEPHRINE (AUTOINJECTOR)?
Summary for EPINEPHRINE (AUTOINJECTOR)
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 7 |
| Raw Ingredient (Bulk) Api Vendors: | 88 |
| Clinical Trials: | 3 |
| DailyMed Link: | EPINEPHRINE (AUTOINJECTOR) at DailyMed |
-patent-expirations.png "EPINEPHRINE (AUTOINJECTOR) drug patent expirations")
Recent Clinical Trials for EPINEPHRINE (AUTOINJECTOR)
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Nasus Pharma | PHASE1 |
| Lawson Health Research Institute | Phase 2/Phase 3 |
| Miltenyi Biomedicine GmbH | Phase 4 |
Pharmacology for EPINEPHRINE (AUTOINJECTOR)
| Drug Class | Catecholamine alpha-Adrenergic Agonist beta-Adrenergic Agonist |
| Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Agonists |
US Patents and Regulatory Information for EPINEPHRINE (AUTOINJECTOR)
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Pharms Usa | EPINEPHRINE (AUTOINJECTOR) | epinephrine | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | 090589-002 | Aug 16, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Teva Pharms Usa | EPINEPHRINE (AUTOINJECTOR) | epinephrine | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | 090589-001 | Aug 16, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
